Yes. Thank you.
Mr. Morrison commented on the act and the risk with all medication. I'd like to go back to my first and my key point.
In 1998 this Standing Committee on Health made 53 recommendations, number one of which was that NHPs are not drugs and they should not be treated as such.
I think anything that's too risky requires a prescription. When we talk about this issue, we talk about consumer education. We work extensively and we collaborate with Health Canada and we speak in our public pieces about consulting with your health care practitioner. I think working on a collaborative message around that education and making consumers aware is where we would like to go.
Patients and consumers do need to take some responsibility, and we would certainly like to educate them, but as you indicated, Ms. Davies, the risk is so minimal that's not where we think we need to be.
The standing committee agreed that these products are not drugs, and I think that's where we should rest.
Thank you.